Trial Details
RECRUITINGBasic Information
| Clinical ID | c101 |
|---|---|
| Identifier | NCT05986136 |
| Trial Title | Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Mesalamine|DRUG: Dapagliflozin 10mg Tab |
Participant Information
| Sponsor | Mostafa Bahaa |
|---|---|
| City | Mansoura |
| Country/Region | Egypt |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2023-08-20 |
|---|---|
| Primary Completion Date | 2025-08-20 |
| Completion Date | 2028-07-20 |